This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice.  The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis.  Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation.  This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized.  The book presents insights from experts across disciplines to emphasize the importance of collaborative care.  Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.

Содержание